Pharmacy Transparency an Option for Medicare Part D Plan Sponsors Amid Market Shake-ups, Financial Pressures
The shifting Medicare market promises big changes for Part D plan sponsors and enrollees alike. RxSS is tracking this evolution ...
- Select Category
- Chronic Conditions
- Engagement
- Events
- Healthcare Costs
- Media
- Medication Adherence
- Member Stories
- Our Team
- Privacy and Security
- Product
- Success Stories
- Thought Leadership
- Transparency
- Uncategorized
- Select Category
- Chronic Conditions
- Engagement
- Events
- Healthcare Costs
- Media
- Medication Adherence
- Member Stories
- Our Team
- Privacy and Security
- Product
- Success Stories
- Thought Leadership
- Transparency
- Uncategorized
The Great 2023 Humira Biosimilars Watch Is On – Here’s Where to Focus
Up to 10 competing products for Humira are on the way in 2023. What should ...
Diabetes by the Numbers, and the Importance of Affordable Medication
Some lesser-known facts about this chronic condition underscore the importance of medication adherence, and the ...
A Q&A on the IRA
The Inflation Reduction Act has the potential to lower prescription drug costs for millions of ...
The Adderall Shortage Is Real – Here’s How RxSS Helps Members
We know many members are scrambling to find pharmacies with the common ADHD medication in ...
Humira Biosimilars and other Biologic Alternatives
A wave of FDA-approved biosimilars for Humira and other costly biologics will enter the U.S. ...
Prescription Drug Options – Pharmacist Curated, Doctor Approved
Members shouldn't confuse our clinical suggestions for intervention. Medication decisions are between patient and doctor. ...
Considering a PBM’s Savings Tool? 10 Questions to Ask Right Now
Free PBM tools can help members get more from their pharmacy benefits, maybe even save ...
Drug Cost Comparison Tools and Healthcare Cost Transparency Come to Life
Seemingly since the beginning of time, consumers have rarely known what a doctor visit, medical ...
Specialty Copay Programs – Accumulate, Maximize or Avoid?
Utilization of specialty medications continues to rise, and so do costs for patients and plan ...
Stay COnnected
Share your email and once a month we’llsend you industry news and insights.
